Literature DB >> 22150441

Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans.

Zachary A Marcum1, Megan E Amuan, Joseph T Hanlon, Sherrie L Aspinall, Steven M Handler, Christine M Ruby, Mary Jo V Pugh.   

Abstract

OBJECTIVES: To describe the prevalence of unplanned hospitalizations caused by adverse drug reactions (ADRs) in older veterans and to examine the association between this outcome and polypharmacy after controlling for comorbidities and other patient characteristics.
DESIGN: Retrospective cohort.
SETTING: Veterans Affairs Medical Centers. PARTICIPANTS: Six hundred seventy-eight randomly selected unplanned hospitalizations of older (aged ≥ 65) veterans between October 1, 2003, and September 30, 2006. MEASUREMENTS: Naranjo ADR algorithm, ADR preventability, and polypharmacy (0-4, 5-8, and ≥9 scheduled medications).
RESULTS: Seventy ADRs involving 113 drugs were found in 68 (10%) hospitalizations of older veterans, of which 25 (36.8%) were preventable. Extrapolating to the population of more than 2.4 million older veterans receiving care during the study period, 8,000 hospitalizations may have been unnecessary. The most common ADRs that occurred were bradycardia (n = 6; beta-blockers, digoxin), hypoglycemia (n = 6; sulfonylureas, insulin), falls (n = 6; antidepressants, angiotensin-converting enzyme inhibitors), and mental status changes (n = 6; anticonvulsants, benzodiazepines). Overall, 44.8% of veterans took nine or more outpatient medications and 35.4% took five to eight. Using multivariable logistic regression and controlling for demographic, health-status, and access-to-care variables, polypharmacy (≥9 and 5-8) was associated with greater risk of ADR-related hospitalization (adjusted odds ratio (AOR) = 3.90, 95% confidence interval (CI) = 1.43-10.61 and AOR = 2.85, 95% CI = 1.03-7.85, respectively).
CONCLUSION: ADRs, determined using a validated causality algorithm, are a common cause of unplanned hospitalization in older veterans, are frequently preventable, and are associated with polypharmacy.
© 2011, Copyright the Authors Journal compilation © 2011, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2011        PMID: 22150441      PMCID: PMC3258324          DOI: 10.1111/j.1532-5415.2011.03772.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  43 in total

1.  High rates of adverse drug events in a highly computerized hospital.

Authors:  Jonathan R Nebeker; Jennifer M Hoffman; Charlene R Weir; Charles L Bennett; John F Hurdle
Journal:  Arch Intern Med       Date:  2005-05-23

Review 2.  Which drugs cause preventable admissions to hospital? A systematic review.

Authors:  R L Howard; A J Avery; S Slavenburg; S Royal; G Pipe; P Lucassen; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06-26       Impact factor: 4.335

3.  Clinically important drug-disease interactions and their prevalence in older adults.

Authors:  Catherine I Lindblad; Joseph T Hanlon; Cynthia R Gross; Richard J Sloane; Carl F Pieper; Emily R Hajjar; Christine M Ruby; Kenneth E Schmader
Journal:  Clin Ther       Date:  2006-08       Impact factor: 3.393

Review 4.  Epidemiology of medication-related adverse events in nursing homes.

Authors:  Steven M Handler; Rollin M Wright; Christine M Ruby; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2006-09

5.  Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003.

Authors:  Min Zhang; C D'Arcy J Holman; David B Preen; Kate Brameld
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

6.  The impact of epilepsy on health status among younger and older adults.

Authors:  Mary Jo V Pugh; Laurel A Copeland; John E Zeber; Joyce A Cramer; Megan E Amuan; Jose E Cavazos; Lewis E Kazis
Journal:  Epilepsia       Date:  2005-11       Impact factor: 5.864

7.  Monitoring of drugs with a narrow therapeutic range in ambulatory care.

Authors:  Marsha A Raebel; Nikki M Carroll; Susan E Andrade; Elizabeth A Chester; Jennifer Elston Lafata; Adrianne Feldstein; Margaret J Gunter; Winnie W Nelson; Steven R Simon; K Arnold Chan; Robert L Davis; Richard Platt
Journal:  Am J Manag Care       Date:  2006-05       Impact factor: 2.229

8.  Unnecessary drug use in frail older people at hospital discharge.

Authors:  Emily R Hajjar; Joseph T Hanlon; Richard J Sloane; Catherine I Lindblad; Carl F Pieper; Christine M Ruby; Laurence C Branch; Kenneth E Schmader
Journal:  J Am Geriatr Soc       Date:  2005-09       Impact factor: 5.562

9.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

10.  Adverse drug events resulting from patient errors in older adults.

Authors:  Terry S Field; Kathleen M Mazor; Becky Briesacher; Kristin R Debellis; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2007-02       Impact factor: 5.562

View more
  75 in total

1.  Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.

Authors:  Consuelo Pedrós; Francesc Formiga; Xavier Corbella; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2015-11-07       Impact factor: 2.953

2.  Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.

Authors:  Soojung Hong; Ju Hyun Lee; Eun Kyeong Chun; Kwang-Il Kim; Jin Won Kim; Se Hyun Kim; Yun-Gyoo Lee; In Gyu Hwang; Jin Young Kim; Su-Jin Koh; Yoon Ho Ko; Seong Hoon Shin; In Sook Woo; Tae-Yong Kim; Ji Yeon Baek; Hyun Jung Kim; Hyo Jung Kim; Myung Ah Lee; Jung Hye Kwon; Yong Sang Hong; Hun-Mo Ryoo; Jee Hyun Kim
Journal:  Oncologist       Date:  2019-11-27

3.  Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

Authors:  Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortíz; Inmaculada Bellido-Estévez
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

4.  Renal denervation in the treatment of resistant arterial hypertension.

Authors:  Thomas Lambert; Wilhelm Schützenberger; Clemens Steinwender
Journal:  Wien Med Wochenschr       Date:  2014-11-14

Review 5.  Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.

Authors:  T J Oscanoa; F Lizaraso; Alfonso Carvajal
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

6.  Characterization of adverse drug reactions causing admission to an intensive care unit.

Authors:  Camilo Rojas-Velandia; Jair Ruiz-Garzón; Juan-Carlos Moscoso-Alcina; Álvaro Vallejos-Narvaéz; Jenny Castro-Canoa; Yuri Bustos-Martínez; Max Flórez-Cutiva; Mabel Contreras-Muñoz; Jully-Carolina Gómez-Gil; Carlos-Alberto Calderón-Ospina
Journal:  Br J Clin Pharmacol       Date:  2017-01-10       Impact factor: 4.335

7.  Determining the incidence of drug-associated acute kidney injury in nursing home residents.

Authors:  Steven M Handler; Pui Wen Cheung; Colleen M Culley; Subashan Perera; Sandra L Kane-Gill; John A Kellum; Zachary A Marcum
Journal:  J Am Med Dir Assoc       Date:  2014-05-10       Impact factor: 4.669

8.  Association Between Functional Impairment and Medication Burden in Adults with Heart Failure.

Authors:  Parag Goyal; Joanna Bryan; Jerard Kneifati-Hayek; Madeline R Sterling; Samprit Banerjee; Mathew S Maurer; Mark S Lachs; Monika M Safford
Journal:  J Am Geriatr Soc       Date:  2018-11-29       Impact factor: 5.562

Review 9.  Cardiac Rehabilitation to Optimize Medication Regimens in Heart Failure.

Authors:  Parag Goyal; Eiran Z Gorodeski; Zachary A Marcum; Daniel E Forman
Journal:  Clin Geriatr Med       Date:  2019-06-21       Impact factor: 3.076

Review 10.  Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Authors:  Kasia J Lipska; Harlan Krumholz; Tacara Soones; Sei J Lee
Journal:  JAMA       Date:  2016-03-08       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.